Search Within

Martin Stuart Tallman

  1. "2017"
Formats
  1. Meeting Abstract (34)
  2. Journal Article (27)
Groups
  1. Adult Leukemia (61)
  2. Center for Hematologic Malignancies (61)
  3. Department of Medicine (61)
  4. Hematologic Malignancies, Division of (61)
  5. Executive Committee, Center for Hematologic Malignancies (15)
  6. GSK Faculty (15)

More Groups

People
  1. Eytan Stein (16)
  2. Ross Levine (12)
  3. Sean Devlin (8)
  4. Jae Park (6)
  5. Bartlomiej Getta (4)
  6. Yanming Zhang (4)

More People

Years
  1. 2017 (61)
Publications
  1. Blood (32)
  2. Journal of Clinical Oncology (5)
  3. Biology of Blood and Marrow Transplantation (4)
  4. Annals of Hematology (3)
  5. Leukemia (3)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (32)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (5)
  4. Elsevier Inc. (4)
  5. Springer (3)
  6. Elsevier Ltd (2)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The addition of midostaurin to standard chemotherapy decreases cumulative incidence of relapse (CIR) in the international prospective randomized, placebo-controlled, double-blind trial (CALGB 10603 / RATIFY [Alliance]) for newly diagnosed acute myeloid leukemia (AML) patients with FLT3 mutations
    Meeting Abstract

    Stone, R. M.; Mandrekar, S. J.; Sanford, B. L.; Laumann, K.; Geyer, S. M.; Bloomfield, C. D.; Dohner, K.; Thiede, C.; Marcucci, G.; Lo Coco, F.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Genomic landscapes in elderly AML
    Meeting Abstract

    Rapaport, F.; Baslan, T.; Wang, L.; Sheridan, C.; Lee, T.; Hricik, T.; de Massy, M. R.; Telis, L.; Neelamraju, Y.; Medina, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Enasidenib monotherapy is effective and well-tolerated in patients with previously untreated mutant-IDH2 (m IDH2) acute myeloid leukemia (AML)
    Meeting Abstract

    Pollyea, D. A.; Tallman, M. S.; De Botton, S.; DiNardo, C. D.; Kantarjian, H. M.; Collins, R. H.; Stein, A. S.; Xu, Q.; Tosolini, A.; Gupta, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Combining gene mutation with gene expression data improves outcomes prediction in acute promyelocytic leukemia
    Meeting Abstract

    Lucena-Araujo, A. R.; Pereira-Martins, D. A.; Koury, L. C. A.; Coelho-Silva, J. L.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; Pasquini, R.; Chiattone, C.; Fagundes, E. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • An analysis of maintenance therapy and post-midostaurin outcomes in the international prospective randomized, placebo-controlled, double-blind trial (CALGB 10603/RATIFY [Alliance]) for newly diagnosed acute myeloid leukemia (AML) patients with FLT3 mutations
    Meeting Abstract

    Larson, R. A.; Mandrekar, S. J.; Sanford, B. L.; Laumann, K.; Geyer, S. M.; Bloomfield, C. D.; Thiede, C.; Prior, T. W.; Dohner, K.; Marcucci, G.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Characteristics and outcome of patients with acute myeloid leukemia and t(6;9)(p22;q34)
    Meeting Abstract

    Kayser, S.; Hills, R. K.; Luskin, M. R.; Brunner, A. M.; Shaw, C.; Westermann, J.; Menghrajani, K.; Baer, M. R.; Elliott, M. A.; Perl, A. E.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Venetoclax combined with either a hypomethylating agent or low-dose cytarabine shows activity in relapsed and refractory myeloid malignancies
    Meeting Abstract

    Goldberg, A. D.; Horvat, T. Z.; Hsu, M.; Devlin, S. M.; Cuello, B. M.; Daley, R. J.; King, A. C.; Buie, L. W.; Glass, J. L.; Mauro, M. J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Lineage deconvolution using chromatin accessibility and DNA methylation shows a spectrum of lineage characteristics and differentiation states across acute leukemias
    Meeting Abstract

    Glass, J. L.; Palia, A. J.; Garrett-Bakelman, F. E.; Koche, R.; Levine, R. L.; Tallman, M. S.; Dillon, R. J.; Grimwade, D.; Ferrando, A. A.; Valk, P. J. M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1
    Meeting Abstract

    Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Results from an ongoing phase 1 study indicate ACDT-301 (camidanlumab tesirine) is well-tolerated in patients with relapsed or refractory CD25-positive acute leukemia
    Meeting Abstract

    Goldberg, A. D.; Tallman, M. S.; Solh, M. M.; Ungar, D.; Rizzieri, D. A.; Walter, R. B.; Spira, A. I.; Chung, K. Y.; Stock, W.; He, S.; more...
    Blood (2017)

    Fulltext@MSK | Save